Author + information
- Leif Thuesen,
- Ivy I. Modrau,
- Per Hostrup Nielsen,
- Hans Erik Botker,
- Evald H. Christiansen,
- Lars R. Krusell,
- Steen D. Kristiansen,
- Anne K. Kaltoft,
- Michael Maeng,
- Christian J. Terkelsen and
- Jens F. Lassen
To assess procedural feasibility and early safety of hybrid coronary revascularization, combining off–pump left internal mammary artery grafting to the left descendent coronary artery (LAD) through an inferior J–hemisternotomy (JOPCAB) and percutaneous coronary intervention (PCI) of non–LAD lesions.
A total of 100 consecutive patients with multivessel coronary artery disease involving LAD were included in this prospective registry.
JOPCAB was performed prior to PCI in 89 (89%) patients, and PCI was scheduled prior to surgery in 11 (11%) patients with total occlusion of a non–LAD artery. Two of these patients were treated by CABG, as revascularization by PCI failed. We chose to re–operate one patient with LIMA graft thrombosis by conventional CABG, as the LAD had shown diffuse arteriosclerotic disease at JOPCAB. Thus, the procedural success rate was 97%. One month after completed hybrid intervention, we observed no deaths. There was one stroke on the fourth postoperative day and two procedure–related, but no spontaneous myocardial infarctions.
Our prospective registry documented excellent procedural feasibility and one–month safety of coronary hybrid revascularization combining JOPCAB with PCI.
Poster Sessions, Expo North
Saturday, March 09, 2013, 3:45 p.m.–4:30 p.m.
Session Title: Multivessel Disease
Abstract Category: 45. TCT@ACC–i2: Coronary Intervention, Multivessel disease
Presentation Number: 2104–261
- 2013 American College of Cardiology Foundation